Compare ICFI & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICFI | CERT |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2006 | 2020 |
| Metric | ICFI | CERT |
|---|---|---|
| Price | $85.99 | $8.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $99.25 | $11.67 |
| AVG Volume (30 Days) | 134.8K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $1,229,162,000.00 | $418,838,000.00 |
| Revenue This Year | $4.12 | $4.18 |
| Revenue Next Year | $5.33 | $5.39 |
| P/E Ratio | $33.21 | ★ N/A |
| Revenue Growth | 3.72 | ★ 8.75 |
| 52 Week Low | $58.83 | $4.45 |
| 52 Week High | $98.03 | $13.88 |
| Indicator | ICFI | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 52.97 |
| Support Level | $84.61 | $7.86 |
| Resistance Level | $90.93 | $8.39 |
| Average True Range (ATR) | 2.29 | 0.33 |
| MACD | -0.50 | 0.01 |
| Stochastic Oscillator | 33.42 | 66.04 |
ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.